cemiplimab
sanofi,regeneron
['cemiplimab']
neoadjuvant cemiplimab elicits encouraging pathologic complete response in cscc #esmo2022 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.